What is Celloxess?
CellOxess is dedicated to advancing human health by developing precise bio-analytical methods for detecting and mitigating oxidative stress, a factor linked to numerous health conditions. The company's focus extends to creating safe and efficacious nutraceuticals designed to enhance systemic and reproductive health. CellOxess serves clients seeking advanced health evaluations and natural prophylactic solutions, positioning itself as a key player in the health-tech and nutraceutical sectors.
How much funding has Celloxess raised?
Celloxess has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Celloxess
PPP
Public-Private Partnership
What's next for Celloxess?
With this recent influx of expansion capital, Celloxess is poised for significant growth and scaling of its operations. The substantial Series B/C stage financing indicates a strong market validation and provides the necessary resources to further develop its bio-analytical technologies and expand its nutraceutical offerings. Future strategic initiatives will likely focus on broadening market reach, enhancing research and development capabilities, and potentially exploring new therapeutic areas related to oxidative stress and overall wellness.
See full Celloxess company page
